An Israeli company last month acquired a reflux-monitoring business from pacemaker manufacturer Medtronic Inc. for $20 million.
Smith, Gambrell & Russell partner Jay Schwartz [photo, left] was lead corporate counsel to Given Imaging Ltd. on the transaction, according to the law firm. Jonathan Minnen is Smith Gambrell’s relationship partner for the Given Imaging account. Minnen leads the firm’s Israel practice group.
Given Imaging, headquartered in Yokneam, Israel, acquired Medtronic’s Bravo-brand pH monitoring business for the diagnosis of gastroesophageal reflux disease. Bravo is a wireless, catheter-free pH test that uses a “disposable capsule temporarily placed in the esophagus that measures pH levels and transmits the data to an external receiver,” according to a news release.
Bravo also “minimizes throat and nasal discomfort associated with conventional catheter-based pH systems and eliminates social embarrassment that accompanies traditional pH testing with no visible indication that a pH test is taking place.”
Other Smith Gambrell attorneys who were involved with the deal include partners Larry Colton on intellectual property; partners Bruce Crabtree III and Eric Mandus and counsel Michelle Edwards on corporate; David Santi on tax; and associates Jeffrey Bekiares, Emily Cacioppo, Julie Sebastian and Chris Yarbrough.